Literature DB >> 9800096

Cognitive functions in chronic locked-in syndrome: a report of two cases.

P Allain1, P A Joseph, J L Isambert, D Le Gall, J Emile.   

Abstract

We describe a 38-year-old woman and a 38-year-old man who have been living in a "locked-in" condition 3 and 2 years, respectively. Extensive neuropsychological testing, carried out with a communication aid system (writing apparatus) which exploited the patients residual eye movements, showed preserved cognitive abilities in spite of the long standing de-efferentation.

Entities:  

Mesh：

Year:  1998        PMID： 9800096     DOI： 10.1016/s0010-9452(08)70520-3

Source DB:  PubMed          Journal:  Cortex        ISSN： 0010-9452            Impact factor:   4.027


  6 in total

Review 1.  Locked-in syndrome.

Authors:  Eimear Smith; Mark Delargy
Journal:  BMJ       Date:  2005-02-19

2.  Psychological adjustment to locked-in syndrome.

Authors:  M Sledz; M Oddy; J G Beaumont
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-06       Impact factor: 10.154

Review 3.  Cognitive rehabilitation in non-communicative brain-damaged patients.

Authors:  Luigi Trojano; Pasquale Moretta; Autilia Cozzolino; Annamaria Saltalamacchia; Anna Estraneo
Journal:  Funct Neurol       Date:  2011 Jan-Mar

4.  Locked-in Syndrome in a Nigerian male with Multiple Sclerosis: a case report and literature review.

Authors:  Imananagha Kobina Keme-Ebi; Asindi Asindi Asindi
Journal:  Pan Afr Med J       Date:  2008-10-30

5.  Cognitive function in the locked-in syndrome.

Authors:  Caroline Schnakers; Steve Majerus; Serge Goldman; Melanie Boly; Philippe Van Eeckhout; Stephane Gay; Frederic Pellas; Valerie Bartsch; Philippe Peigneux; Gustave Moonen; Steven Laureys
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

6.  Diffusion tensor imaging reveals diffuse white matter injuries in locked-in syndrome patients.

Authors:  Mylene Leonard; Felix Renard; Laura Harsan; Julien Pottecher; Marc Braun; Francis Schneider; Pierre Froehlig; Frederic Blanc; Daniel Roquet; Sophie Achard; Nicolas Meyer; Stephane Kremer
Journal:  PLoS One       Date:  2019-04-10       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.